New Delhi, April 27 (IANS) India’s major drugmaker Sun Pharmaceutical Industries on Monday announced that it will acquire New York-listed Organon & Co in an all-cash deal valued at $11.75 billion, its biggest overseas acquisition to date.Under the agreement, the pharmaceutical firm will acquire 100 per cent of Organon’s outstanding shares at $14 per share, translating into an enterprise valuation of $11.75 billion and an equity value of around $3.99 billion, the company said in an exchan…
Trending
- Vadhandhi Season 2 Review (2026): A Gripping, Powerful Thriller Anchored By Sasikumar’s Career-Best Performance
- Picture 2026 Movie Review: A Heartwarming Kannada-Tulu Family Entertainer That Wins You Over
- Thudakkam Movie Review (2026): Vismaya Mohanlal Delivers a Powerful, Star-Making Debut
- Operation Safed Sagar Review 2026: A Powerful Tribute To Kargil’s Air Warriors
- DC Movie Review 2026: Wamiqa Gabbi’s Fierce Performance Make This Saga a Massive Triumph
- Korean Kanakaraju Movie Review 2026: An Unmissable Cross-Border Ride
- Ohh My Dog Movie Review 2026: A Heartwarming Triumph Of Loyalty & Love
- G.D.N. Movie Review: Madhavan’s Powerhouse Biopic Is a Tribute to India’s Forgotten Edison